1ZIPES D P,CAMM A J,BORGGREFE M,et al.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary[J].Eur Heart J,2006,27(17):2099.
2DANIEL G,KRAUSER M D,ALAN Z,et al.Severe ataxia caused by amiodarone[J].Amer J Cadr,2005,96(10):1463-1464.
4HOHNLOSER S H,CONNOLLY S J,CRIJNS H J,et al.Rationale and design of ATHENA:a placebo-controlled,double-blind,parallel arm trialto assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause inpatients with atrial fibrillation/atrial flutter[J].J Cardiovasc Electrophysiol,2008,19(1):69-73.
6KOBER L,TORP-PEDERSEN C,MCMURRAY J J V,et al.Increased mortality after dronedarone therapy for severe heart failure[J].N Engl J Med,2008,358(12):2678-2687.
7SATO S,WATANABE K,ISHIDA T,et al.Amiodarone-induced pneumonitis associated with marked eosinophilia in BALF[J].Nippon Naika Gakkai Zasshi,2006,96(3):356-358.
8ZAREBA K M.Dronedarone:a new antiarrhythmicagent[J].Drugs Today (Barc),2006,42(1):75-86.
9ISKANDAR S B,ABI-SALEH B,KEITH R L,et al.Amiodarone induced alveolar hemorrhage[J].South Med J,2006,99(3):383-387.
10SINGH B N,CONNOLLY S J,CRIJNS H J,et al.Dronedarone for maintenance of sinusrhythm in atrial fibrillation or flutter[J].N Engl J Med,2007,357(7):987-999.
7Siniakowicz RM, Narula D, Suster B, et al. Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol, 2001,12:431-436.
8Dusman RE, Staton MS, Miles WM, et al. Clinical features of amiodarone -induced pulmonary toxicity. Circulation,1990, 82:51-59.
9Siddoway LA. Amiodarone: guidelines for use and monitoring.American Family Physicion,2003,68:2189-2196.
10Goldschlager N, Epstein AE, Naccarelli G,et al. Practice guideline for clinicians who treat patients with amiodarone. Arch Intern Med,2000,160:1741-1748.
